Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor
Public ClinicalTrials.gov record NCT02006654. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomised, Double-blind, Parallel-group, Placebo-controlled Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To establish efficacy of idalopirdine as adjunctive therapy to acetylcholinesterase inhibitors (AChEIs) for symptomatic treatment of patients with mild-moderate Alzheimer's disease (AD).
Study identification
- NCT ID
- NCT02006654
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 734 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2014 (Type not available)
- Primary completion
- Jan 2017 (Actual)
- Completion
- Jan 2017 (Actual)
- Last update posted
- Feb 7, 2018
2014 – 2017
United States locations
- U.S. sites
- 26
- U.S. states
- 15
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| US612 | Mesa | Arizona | — | — |
| US625 | Bellflower | California | — | — |
| US626 | Costa Mesa | California | — | — |
| US604 | Oxnard | California | — | — |
| US627 | Santa Ana | California | — | — |
| US609 | Danbury | Connecticut | — | — |
| US614 | Norwalk | Connecticut | — | — |
| US608 | Deerfield Beach | Florida | — | — |
| US616 | Hialeah | Florida | — | — |
| US620 | Miami | Florida | — | — |
| US603 | North Palm Beach | Florida | — | — |
| US631 | Port Charlotte | Florida | — | — |
| US622 | Elk Grove Village | Illinois | — | — |
| US611 | Elkhart | Indiana | — | — |
| US606 | Prairie Village | Kansas | — | — |
| US601 | Farmington Hills | Michigan | — | — |
| US607 | St Louis | Missouri | — | — |
| US613 | Lawrenceville | New Jersey | — | — |
| US635 | Paterson | New Jersey | — | — |
| US630 | Toms River | New Jersey | — | — |
| US621 | Albany | New York | — | — |
| US632 | Staten Island | New York | — | — |
| US633 | Charlotte | North Carolina | — | — |
| US623 | Oklahoma City | Oklahoma | — | — |
| US618 | Norristown | Pennsylvania | — | — |
| US619 | Houston | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 81 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02006654, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 7, 2018 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02006654 live on ClinicalTrials.gov.